Automated Microbiology Market - Forecasts from 2017 to 2022
Automated Microbiology Market is estimated to grow to US$5.850 billion by 2022, increasing from US$3.770 billion in 2017, at a compound annual growth rate of 9.19% over the forecast period.
This research study examines the Automated Microbiology market by diagnostic technologies, end users, and geography. Major drivers, restraints, and opportunities have been mentioned to provide an exhaustive picture of the market. Furthermore, the current market trends related to the demand, supply, and sales, in addition to the recent developments, have been provided in this report. The report also analyzes key players in the Automated Microbiology market. The report provides comprehensive forecast up to the period 2022 for various key segments, with 2016 as the base year.
The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical segments. Moreover, the research study analyzes the overall regulatory framework of Automated Microbiology market, offering stakeholders a better understanding of the key factors affecting the overall market environment.
The first step towards determining the Automated Microbiology market size involves identifying key players and the revenue contribution of the overall business or relevant segment aligned to the study in consideration through extensive secondary research. This also includes various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others. Both bottom-up and top-down approaches are utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the Automated Microbiology value chain across key enterprises operating as manufacturers, suppliers, and distributors. The last phase is providing intelligence in the form of presentation, charts, graphics and other different formats helping the clients in faster and efficient understanding of the market. Under this phase complete market engineering is involved which includes analyzing the gathered data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Competitive intelligence section deals with major players in the market, their market share analysis, growth strategies, products, financials, and recent investments among others. Key industry players profiled as part of this section are Bio-Rad Laboratories, Inc and QIAGEN.
Segments covered under the Automated Microbiology market report are as below:
By Diagnostic Technologies
Detection Techniques
DNA Sequencing
DNA and RNA Probe Technology
By End User
Biotechnology Industries
Clinical Laboratories
Others
Geography
Americas
North America
S.
Canada
Mexico
Others
South America
Brazil
Argentina
Others
Europe Middle East and Africa
Europe
UK
Germany
France
Others
Middle East and Africa
Saudi Arabia
Israel
Others
Asia Pacific
Japan
China
India
Australia
Others
This research study examines the Automated Microbiology market by diagnostic technologies, end users, and geography. Major drivers, restraints, and opportunities have been mentioned to provide an exhaustive picture of the market. Furthermore, the current market trends related to the demand, supply, and sales, in addition to the recent developments, have been provided in this report. The report also analyzes key players in the Automated Microbiology market. The report provides comprehensive forecast up to the period 2022 for various key segments, with 2016 as the base year.
The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical segments. Moreover, the research study analyzes the overall regulatory framework of Automated Microbiology market, offering stakeholders a better understanding of the key factors affecting the overall market environment.
The first step towards determining the Automated Microbiology market size involves identifying key players and the revenue contribution of the overall business or relevant segment aligned to the study in consideration through extensive secondary research. This also includes various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others. Both bottom-up and top-down approaches are utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the Automated Microbiology value chain across key enterprises operating as manufacturers, suppliers, and distributors. The last phase is providing intelligence in the form of presentation, charts, graphics and other different formats helping the clients in faster and efficient understanding of the market. Under this phase complete market engineering is involved which includes analyzing the gathered data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Competitive intelligence section deals with major players in the market, their market share analysis, growth strategies, products, financials, and recent investments among others. Key industry players profiled as part of this section are Bio-Rad Laboratories, Inc and QIAGEN.
Segments covered under the Automated Microbiology market report are as below:
By Diagnostic Technologies
Detection Techniques
DNA Sequencing
DNA and RNA Probe Technology
By End User
Biotechnology Industries
Clinical Laboratories
Others
Geography
Americas
North America
S.
Canada
Mexico
Others
South America
Brazil
Argentina
Others
Europe Middle East and Africa
Europe
UK
Germany
France
Others
Middle East and Africa
Saudi Arabia
Israel
Others
Asia Pacific
Japan
China
India
Australia
Others
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Segmentation
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Supplier Outlook
4.6. Industry Outlook
4.7. Porter’s 5 Forces Analysis
4.8. Industry Value Chain Analysis
4.9. Industry Regulations
4.10. Scenario Analysis
5. GLOBAL AUTOMATED MICROBIOLOGY MARKET FORECAST BY DIAGNOSTIC TECHNOLOGIES (US$ BILLION)
5.1. Detection Techniques
5.1.1. Market Size and Forecasts to 2022
5.2. DNA Sequencing
5.2.1. Market Size and Forecasts to 2022
5.3. DNA and RNA Probe Technology
5.3.1. Market Size and Forecasts to 2022
6. GLOBAL AUTOMATED MICROBIOLOGY MARKET FORECAST BY END USER (US$ BILLION)
6.1. Biotechnology Industries
6.1.1. Market Size and Forecasts to 2022
6.2. Clinical Laboratories
6.2.1. Market Size and Forecasts to 2022
6.3. Others
6.3.1. Market Size and Forecasts to 2022
7. GLOBAL AUTOMATED MICROBIOLOGY MARKET FORECAST BY GEOGRAPHY (US$ BILLION)
7.1. Americas
7.1.1. North America
7.1.1.1. U.S.
7.1.1.2. Canada
7.1.1.3. Mexico
7.1.1.4. Others
7.1.2. South America
7.1.2.1. Brazil
7.1.2.2. Argentina
7.1.2.3. Others
7.2. Europe Middle East and Africa
7.2.1. Europe
7.2.1.1. UK
7.2.1.2. Germany
7.2.1.3. France
7.2.1.4. Others
7.2.2. Middle East and Africa
7.2.2.1. Saudi Arabia
7.2.2.2. Israel
7.2.2.3. Others
7.3. Asia Pacific
7.3.1. Japan
7.3.2. China
7.3.3. India
7.3.4. Australia
7.3.5. Others
8. COMPETITIVE INTELLIGENCE
8.1. Market Share Analysis
8.2. Investment Analysis
8.3. Recent Deals
8.4. Strategies of Key Players
9. COMPANY PROFILES
9.1. Bio-Rad Laboratories, Inc.
9.1.1. Overview
9.1.2. Financials
9.1.3. Products and Services
9.1.4. Recent Developments
9.2. QIAGEN
9.2.1. Overview
9.2.2. Financials
9.2.3. Products and Services
9.2.4. Recent Developments
9.3. BECKMAN COULTER
9.3.1. Overview
9.3.2. Financials
9.3.3. Products and Services
9.3.4. Recent Developments
9.4. BD (Becton Dickinson)
9.4.1. Overview
9.4.2. Financials
9.4.3. Products and Services
9.4.4. Recent Developments
9.5. bioMerieux
9.5.1. Overview
9.5.2. Financials
9.5.3. Products and Services
9.5.4. Recent Developments
9.6. List is not exhaustive*
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Segmentation
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Supplier Outlook
4.6. Industry Outlook
4.7. Porter’s 5 Forces Analysis
4.8. Industry Value Chain Analysis
4.9. Industry Regulations
4.10. Scenario Analysis
5. GLOBAL AUTOMATED MICROBIOLOGY MARKET FORECAST BY DIAGNOSTIC TECHNOLOGIES (US$ BILLION)
5.1. Detection Techniques
5.1.1. Market Size and Forecasts to 2022
5.2. DNA Sequencing
5.2.1. Market Size and Forecasts to 2022
5.3. DNA and RNA Probe Technology
5.3.1. Market Size and Forecasts to 2022
6. GLOBAL AUTOMATED MICROBIOLOGY MARKET FORECAST BY END USER (US$ BILLION)
6.1. Biotechnology Industries
6.1.1. Market Size and Forecasts to 2022
6.2. Clinical Laboratories
6.2.1. Market Size and Forecasts to 2022
6.3. Others
6.3.1. Market Size and Forecasts to 2022
7. GLOBAL AUTOMATED MICROBIOLOGY MARKET FORECAST BY GEOGRAPHY (US$ BILLION)
7.1. Americas
7.1.1. North America
7.1.1.1. U.S.
7.1.1.2. Canada
7.1.1.3. Mexico
7.1.1.4. Others
7.1.2. South America
7.1.2.1. Brazil
7.1.2.2. Argentina
7.1.2.3. Others
7.2. Europe Middle East and Africa
7.2.1. Europe
7.2.1.1. UK
7.2.1.2. Germany
7.2.1.3. France
7.2.1.4. Others
7.2.2. Middle East and Africa
7.2.2.1. Saudi Arabia
7.2.2.2. Israel
7.2.2.3. Others
7.3. Asia Pacific
7.3.1. Japan
7.3.2. China
7.3.3. India
7.3.4. Australia
7.3.5. Others
8. COMPETITIVE INTELLIGENCE
8.1. Market Share Analysis
8.2. Investment Analysis
8.3. Recent Deals
8.4. Strategies of Key Players
9. COMPANY PROFILES
9.1. Bio-Rad Laboratories, Inc.
9.1.1. Overview
9.1.2. Financials
9.1.3. Products and Services
9.1.4. Recent Developments
9.2. QIAGEN
9.2.1. Overview
9.2.2. Financials
9.2.3. Products and Services
9.2.4. Recent Developments
9.3. BECKMAN COULTER
9.3.1. Overview
9.3.2. Financials
9.3.3. Products and Services
9.3.4. Recent Developments
9.4. BD (Becton Dickinson)
9.4.1. Overview
9.4.2. Financials
9.4.3. Products and Services
9.4.4. Recent Developments
9.5. bioMerieux
9.5.1. Overview
9.5.2. Financials
9.5.3. Products and Services
9.5.4. Recent Developments
9.6. List is not exhaustive*
